Human and non-human animal use of microbial anaplerotic oil

US10874131B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10874131-B2
Application numberUS-201916720972-A
CountryUS
Kind codeB2
Filing dateDec 19, 2019
Priority dateDec 22, 2017
Publication dateDec 29, 2020
Grant dateDec 29, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are techniques and systems for producing microbials having anaplerotic oils that are rich in odd-chain fatty acids, and other beneficial components, at higher concentrations than those present in other natural dietary sources of OCFA, at lower cost, and higher production yield. Further, disclosed are examples of incorporation of these higher concentration OCFA products into food for human and non-human animal consumption.

First claim

Opening claim text (preview).

What is claimed is: 1. A food additive comprising microalgal anaplerotic oil rich in saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) odd-chain fatty acids (OCFA), the microalgal anaplerotic oil derived from Aurantiochytrium acetophilum HS399 microalgae strain cultured aerobically with added propionate and a continuous supply of oxygen resulting in elevated levels of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA in a microalgal mass of the Aurantiochytrium acetophilum HS399 microalgae strain, wherein: at least five percent of the microalgal anaplerotic oil from the Aurantiochytrium acetophilum HS399 microalgae strain's total fatty acid (TFA) content is saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) odd-chain fatty acids (OCFA); and at least one percent cell dry weight (CDW) of the microalgal mass from the Aurantiochytrium acetophilum HS399 microalgae strain is saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) odd-chain fatty acids (OCFA). 2. The food additive of claim 1 wherein pentadecanoic acid makes up greater than eighteen percent of the TFA content of the microalgal anaplerotic oil. 3. The food additive of claim 1 wherein heptadecanoic acid makes greater than five percent of the TFA content of the microalgal anaplerotic oil. 4. The food additive of claim 1 wherein saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA comprise a range of 5 to 60% of the TFA content of the microalgal anaplerotic oil. 5. The food additive of claim 1 , wherein the microalgal mass is processed for human and non-human animal consumption, the microalgal mass comprising the microalgal anaplerotic oil rich in saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA. 6. The food additive of claim 1 , wherein the food additive is substantially free of phytanic acid. 7. A food rich in saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) odd-chain fatty acids (OCFA) for consumption by human and non-human animals, the food comprising: an amount of microalgal anaplerotic oil derived from Aurantiochytrium acetophilum HS399 microalgae strain cultured aerobically with an added propionate precursor or added propionate and a continuous supply of oxygen, resulting in elevated levels of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA in a microalgal mass, the microalgal anaplerotic oil comprising: at least five percent of the microalgal anaplerotic oil from the microalgal strain's total fatty acid (TFA) content is odd-chain fatty acids (OCFA); and at least one percent cell dry weight (CDW) of the microalgal mass from the microalgal strain is odd-chain fatty acids (OCFA). 8. The food of claim 7 wherein the food containing microalgal anaplerotic oil is animal milk or plant-based substitute milk and wherein the % TFA of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA is at least 10% greater than the % TFA of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA in a substantially identical milk that does not contain the microalgal anaplerotic oil. 9. The milk of claim 8 wherein the milk contains between about 0.9 g/serving and about 10.2 g/serving of microalgal anaplerotic oil. 10. The food of claim 7 wherein the food containing microalgal anaplerotic oil is a dairy-containing product and wherein the % TFA of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA is at least 5.5% greater than the % TFA of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA in a substantially identical dairy-containing product that does not contain the microalgal anaplerotic oil. 11. The dairy-containing product of claim 10 wherein the dairy-containing product contains between about 0.9 g/serving and about 10.2 g/serving of microalgal anaplerotic oil. 12. The food of claim 7 wherein the food containing microalgal anaplerotic oil is a meat product and wherein the % TFA of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA is at least 8.3% greater than the % TFA of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA in a substantially identical meat product that does not contain the microalgal anaplerotic oil. 13. The meat product of claim 12 wherein the meat product is poultry, swine, cattle, lamb, lard, sausages, cured meat, jerky, seafood, or plant-based meat or seafood. 14. The food of claim 7 wherein the food containing microalgal anaplerotic oil is a poultry egg product and wherein the % TFA of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA is at least 13.6% greater than the % TFA of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA in a substantially identical poultry egg product that does not contain the microalgal anaplerotic oil. 15. The poultry egg product of claim 14 wherein the poultry egg product contains 1.7 g of microalgal anaplerotic oil per serving. 16. A processed food product or food component comprising a food additive, the food additive comprising: an amount of anaplerotic oil derived from an Aurantiochytrium microalgae strain cultured in aerobic conditions with added propionate and a continuous supply of oxygen, wherein at least five percent of the total fatty acids (TFA) of the anaplerotic oil are saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA and the saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA make up at least one percent cell dry weight (CDW) of the microalgal mass, wherein the amount of anaplerotic oil in the food additive is determined by: identifying a unit amount of saturated fat that is present in a target food; identifying an amount of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA present in the microalgal anaplerotic oil as a ratio of OCFA amount per unit of microalgal anaplerotic oil, wherein at least five percent of the total fatty acid (TFA) of the microalgal anaplerotic oil are saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA; combining the ratio with the unit amount of saturated fat resulting in the amount of microalgal anaplerotic oil rich in OCFA to incorporate into the target food; and adding the food additive having the determined amount of anaplerotic oil to the target food, wherein the amount of microalgal anaplerotic oil in the food additive is between about 0.9 g/serving and about 10.2 g/serving. 17. The processed food product or food component of claim 16 , wherein the processed food product or food component is animal milk or plant-based substitute milk. 18. The processed food product or food component of claim 16 , wherein the processed food or food component contains the same amount of total fatty acid as the target food that has not been processed, and wherein the processed food product or food component contains a total amount of saturated tridecanoic (C13:0), pentadecanoic (C15:0), and heptadecanoic (C17:0) OCFA that is equal to an amount of even-chain saturated fat in the target food. 19. The processed food product or food component of claim 16 , wherein the Aurantiochytrium microalgae is Aurantiochytrium acetophilum HS399. 20.

Assignees

Inventors

Classifications

  • Algae {; Processes using algae} · CPC title

  • Unicellular algae isolates · CPC title

  • Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof · CPC title

  • A23L29/04Primary

    Fatty acids or derivatives · CPC title

  • Unicellular algae; Culture media therefor (as new plants A01H13/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10874131B2 cover?
Disclosed are techniques and systems for producing microbials having anaplerotic oils that are rich in odd-chain fatty acids, and other beneficial components, at higher concentrations than those present in other natural dietary sources of OCFA, at lower cost, and higher production yield. Further, disclosed are examples of incorporation of these higher concentration OCFA products into food for h…
Who is the assignee on this patent?
Heliae Dev Llc
What technology area does this patent fall under?
Primary CPC classification A23L29/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).